The current TSBX market cap is 8.58M. The company's latest EPS is USD -2.3867 and P/E is -0.16.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 101.29M | 73.3M | 19.31M |
Operating Income | 32.99M | -31.63M | -59.03M |
Net Income | 33.27M | -30.83M | -55.2M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 187.24M | 114.94M | 112.82M |
Total Liabilities | 97.34M | 44.46M | 14.15M |
Total Equity | -81.85M | -101.47M | 98.67M |
Market Cap | 8.58M |
Price to Earnings Ratio | -0.16 |
Price to Sales Ratio | 0.44 |
Price to Cash Ratio | 0.48 |
Price to Book Ratio | 0.09 |
Dividend Yield | - |
Shares Outstanding | 23.13M |
Average Volume (1 week) | 171.41k |
Average Volume (1 Month) | 237.31k |
52 Week Change | -90.95% |
52 Week High | 4.54 |
52 Week Low | 0.3503 |
Spread (Intraday) | 0.06 (14.92%) |
Company Name | Turnstone Biologics Corporation |
Address |
9310 athena circle, suite 300 la jolla, california 92037 |
Website | https:// |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions